TScan Therapeutics (TCRX) Return on Sales (2020 - 2026)
TScan Therapeutics (TCRX) posted quarterly Return on Sales of 0.29% for Q1 2026, down 12.0% year-over-year from 0.33% in Q1 2025, and down 135.32% quarter-over-quarter from 0.12% in Q4 2025.
TScan Therapeutics (TCRX) Return on Sales (2020 - 2026) Analysis & Trends
TScan Therapeutics (TCRX) has reported Return on Sales for 7 consecutive years, with 0.29% the latest figure, recorded in Q1 2026.
- In Q1 2026, Return on Sales fell 12.0% year-over-year to 0.29%; the TTM figure through Mar 2026 stood at 0.15% (up 18.0% YoY), while the FY2025 annual figure was 0.21%, up 30.0% from the prior year.
- Return on Sales slipped to 0.29% in Q1 2026 per TCRX's latest filing, from 0.12% in the prior quarter.
- Across five years, Return on Sales topped out at 0.03% in Q4 2023 and bottomed at 0.7% in Q4 2024.
- Historically, Return on Sales has averaged 0.2% across 5 years, with a median of 0.12% in 2025.
- Annual changes were most pronounced in 2024 — Return on Sales tumbled 67 bps — and 2025, when it surged 58 bps.
- TScan Therapeutics' Return on Sales stood at 0.06% in 2022, then jumped by 56 bps to 0.03% in 2023, then plunged by 2401 bps to 0.7% in 2024, then soared by 82 bps to 0.12% in 2025, then slumped by 135 bps to 0.29% in 2026.
- Business Quant data shows TCRX's Return on Sales at 0.29% in Q1 2026, 0.12% in Q4 2025, and 0.14% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.00% |
| 10 | TScan Therapeutics | 100.62 Mn | 100.62 Mn | - | -0.29% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.29% |
| Mar 31, 2026 | -0.29% |
| Dec 31, 2025 | -0.12% |
| Sep 30, 2025 | -0.14% |
| Jun 30, 2025 | -0.12% |
| Mar 31, 2025 | -0.17% |
| Dec 31, 2024 | -0.70% |
| Sep 30, 2024 | -0.28% |
| Jun 30, 2024 | -0.59% |
| Mar 31, 2024 | -0.53% |
| Dec 31, 2023 | -0.03% |
| Sep 30, 2023 | -0.06% |
| Jun 30, 2023 | -0.08% |
| Mar 31, 2023 | -0.04% |
| Dec 31, 2022 | -0.06% |
| Sep 30, 2022 | -0.05% |
| Jun 30, 2022 | -0.04% |
| Mar 31, 2022 | -0.05% |
| Dec 31, 2021 | -0.05% |
| Sep 30, 2021 | -0.10% |